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Recently, Lohr et al. have published a 
method that identifies sample annotation er-
rors in gene expression data (Lohr et al., 
2015). Surprisingly, 40 % of 45 analyzed 
publicly available datasets including 4913 
patients were affected by erroneous sample 
annotation. The authors conclude that sample 
annotation errors may be a more widespread 
phenomenon as previously expected (Lohr et 
al., 2015). The authors used two strategies for 
identifying sample mix-up. First, a classifier 
was established that differentiates between 
samples from female and male patients. This 
classifier is based on the x-chromosomal 
gene XIST and the y-chromosomal genes 
RPS4Y1 and DDX3Y (Lohr et al., 2015). In 
datasets with similar numbers of male and 
females, approximately half of sample mix-
ups will result in sex mislabeling. A further 
possible error is sample duplication, where 
the same sample is analyzed twice and the 
duplicate is erroneously labeled with another 
patient (Lohr et al., 2015). To identify such 
duplications, a correlation-based strategy was 
used. A strength of the techniques presented 
by Lohr et al. is that they include normaliza-
tion steps which make it possible to apply the 
same algorithm on samples of all datasets. 
The algorithm then differentiates between 
‘correctly classified’ and ‘misclassified’ 
samples. In the analyzed 45 publicly availa-
ble cohorts 18 contained at least one misclas-
sification. The authors also show that delet-
ing the erroneous samples can strongly influ-
ence the number of statistically significant 
prognostic genes. 
Currently, genome-wide data are fre-
quently used in cancer research (Stock et al., 
2015; Sicking et al., 2014; Cadenas et al., 
2014; Mattson et al., 2015). Intensively stud-
ied fields are breast- and ovarian cancer 
(Siggelkow et al., 2012; Godoy et al., 2014; 
Stewart et al., 2012; Schmidt et al., 2012). It 
can be expected that cohorts with only sam-
ples from either females or males have a 
lower risk of sex mislabeling. Therefore, it 
was surprising that an example of mislabeled 
patients was also identified in breast cancer 
patients. For example the well-known 
TRANSBIG cohort contains one female 
node-negative breast cancer patient who in 
reality is a man (Lohr et al., 2015). 
Besides its intensive use in cancer re-
search (Micke et al., 2014; Schmidt et al., 
2008; Botling et al., 2013) genome-wide ex-
pression data are also frequently used in toxi-
cology (Campos et al., 2014; Stöber et al., 
2014; Marchan, 2014a, b; Bolt, 2013; Song et 
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al., 2013; Godoy et al., 2013; Bolt et al., 
2010). The goal of these studies is to obtain 
first evidence of the mechanism of action of 
chemicals (Glahn et al., 2008; Shimada et al., 
2010; Dika Nguea et al., 2008; Hendrickx et 
al., 2014; Shinde et al., 2015; Yao and Costa, 
2014; Gagné et al., 2013; Fang et al., 2014; 
Kim et al., 2012) or to establish classifiers of 
co-regulated gene clusters (Grinberg et al., 
2014; Shao et al., 2014; Krug et al., 2013; 
Godoy et al., 2015; Rempel et al., 2015; 
Doktorova et al., 2012). In these datasets the 
correlation-based classifier for sample dupli-
cation may be helpful. In conclusion, the easy 
to use classifiers published by Lohr and col-
leagues (2015) should be routinely included 
into the analysis of gene array but also RNA 
seq data to reduce the number of erroneous 
sample annotations. 
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